Observed arrival · 2026-09-17
Codebreaker Labs and the Causal Data Layer
A biotech platform edits single-nucleotide variants into primary human cells and measures their effects for immunology, oncology, and rare-disease research.
Field notes
The platform is described as a laboratory-to-dataset workflow: variants are edited into primary human cells, their effects are measured, and the resulting observations are assembled into disease-focused Atlases for genomics AI. The homepage claims one-base-pair causal resolution and parallel editing at the scale of tens of thousands of variants. Three Atlases are identified as being in build, while the underlying datasets and validation details are not exposed on this page.
Observed signals
Read the marks
Editorial observations of this landing page, not a rating.
One card from the complete issue